Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.
about
Mechanisms of dopamine transporter regulation in normal and disease statesGenealogical correspondence of a forebrain centre implies an executive brain in the protostome-deuterostome bilaterian ancestor.Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.In vivo amphetamine action is contingent on αCaMKIIAmphetamine activates calcium channels through dopamine transporter-mediated depolarization.PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA effluxαCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans.Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine ReuptakeAmphetamines, new psychoactive drugs and the monoamine transporter cycle.Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain.Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters.Amphetamine-induced behavior requires CaMKII-dependent dopamine transporter phosphorylation.Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24CA quantitative model of amphetamine action on the 5-HT transporter.A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content.Neurobiological Correlates of Pain Avoidance-Like Behavior in Morphine-Dependent and Non-Dependent Rats.Gβγ subunit activation promotes dopamine efflux through the dopamine transporter.Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.A kinetic account for amphetamine-induced monoamine release.The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.[Researcher of the month].
P2860
Q24598750-C1DB342F-B39F-4405-B0FD-EB551885F4D6Q28603830-1BA59791-3406-4B5A-A489-7EFD37063CD0Q34161514-B3384CB9-232A-4C36-AA94-5524BE81BD8CQ34383082-88F7C123-EEBB-4760-91C7-FFCA896295B5Q34393113-F74E0297-C29C-4648-A318-819820D4AFFBQ34484408-86B4DCBB-2A05-4924-83D3-C271ED56804EQ34523471-EEABCD6F-0905-456E-A275-8EAE6030816BQ35150218-13E85C5E-047F-44DC-8FFD-A014376698A0Q35649527-0EC9F22E-3EDA-46DC-8DE5-EDEC8F948F6BQ35754644-822EFCB7-E7EB-4BFE-98A2-58D5C626160DQ35853599-EB402931-9892-468A-8FFB-873C21A95DEAQ36216082-CD8343CD-AE3C-4EDA-B966-A7FF9752AD15Q36508575-AA1AA5A2-C3D1-44A4-BBDF-3DD820F90573Q37189583-2C1F2AA6-FB65-445B-84B0-095445A0CC70Q39057330-0143FEA1-6CA5-4617-B343-9CAE0C914B1FQ41185924-0016D6B3-A087-4545-93B0-36380FF34A4CQ41922717-ADCA6BC7-772D-4062-8E40-86FA5FD8677EQ41956579-A2A12986-5FAD-4B31-BA10-089448CF11B2Q42771936-EACAC272-CDB0-4F36-BC4A-A5B9677F44AFQ47314731-67859016-9E52-4A74-9490-568F255590DDQ47624474-904CCE26-8D9E-47D1-AFB3-F230B6D05A66Q47758420-49CBF97B-2B97-4202-9690-AAA7219AAF17Q47842905-CDFE0884-3A9C-4FE3-B1A4-142F1CE998AEQ50035451-AB2B8778-71C4-4840-8C1D-361B10639715Q52649972-425CB171-BDEE-463E-BC01-66D2E578AC59Q55058831-83E54943-561E-466F-8190-D8A389BD37FB
P2860
Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ca(2+)/calmodulin-dependent pr ...... cations for Angelman syndrome.
@en
type
label
Ca(2+)/calmodulin-dependent pr ...... cations for Angelman syndrome.
@en
prefLabel
Ca(2+)/calmodulin-dependent pr ...... cations for Angelman syndrome.
@en
P2093
P2860
P50
P356
P1476
Ca(2+)/calmodulin-dependent pr ...... ications for Angelman syndrome
@en
P2093
Marie-Therese Winkler
Oliver Kudlacek
Therese R Montgomery
P2860
P304
29627-29635
P356
10.1074/JBC.M112.367219
P407
P50
P577
2012-07-09T00:00:00Z